Hydrocodone Polistirex And Chlorpheniramine Polistirex Suspension, Extended Release
Product Images NDC 63629-2303

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Hydrocodone Polistirex And Chlorpheniramine Polistirex (NDC 63629-2303). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure 1 (Hydrocodone Polistirex And Chlorpheniramine Polist 1)

FDA Label Image

Structure 2 (Hydrocodone Polistirex And Chlorpheniramine Polist 2)

FDA Label Image

Cup (Hydrocodone Polistirex And Chlorpheniramine Polist 3)

Cup (Hydrocodone Polistirex And Chlorpheniramine Polist 3)
This text provides a conversion chart for teaspoons and milliliters. 1 teaspoon is equivalent to 5 milliliters and 0.5 teaspoon is equivalent to 2.5 milliliters.*
FDA Label Image

Label (Lbl636292303)

Label (Lbl636292303)
Hydrocodone Polistirex and Chlorpheniramine Polistirex ER Suspension is a prescription-only medication containing 10 mg/5ml of Hydrocodone Bitartrate, USP, and 8 mg/5ml of Chlorpheniramine Maleate, USP in a 115 mL bottle. It is essential to keep this medication out of reach of children and store it at a controlled room temperature of 20° to 25°C (68° to 77°F) in a tightly closed light-resistant container. This medication may cause drowsiness. NILD is an unidentified entity, and Aq pajaqeley and Aq painjoejnuey are not understandable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.